Search Results 21-30 of 16715 for Clenpiq

  1. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  2. Mayo Clinic

    Share · Tweet . IMG-20451443. Home; cc-man-taking-pill_mobile. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine ...

  3. Milnacipran (oral route) - Side effects & dosage - Mayo Clinic

    Milnacipran is used to treat a condition called fibromyalgia, which causes muscle pain and stiffness. It belongs to a group of medicines known as selective ...

  4. Pegaptanib (intraocular route) - Side effects & uses - Mayo Clinic

    Pegaptanib is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina of the eye that causes blurring of vision ...

  5. Chemoprevention - Mayo Clinic

    Share · Tweet . IMG-20008453. Home; Chemoprevention. Double your impact! Give Now! Your GivingTuesday gift can go 2X as far.

  6. Alectinib (oral route) - Side effects & dosage - Mayo Clinic

    Your doctor will perform a test to check for the ALK gene before you use this medicine. Alectinib belongs to the group of medicines called antineoplastics ( ...

  7. Lurbinectedin (intravenous route) - Side effects & uses - Mayo Clinic

    Lurbinectedin injection is used to treat metastatic (cancer that has already spread) small cell lung cancer (SCLC) in patients who have received other cancer ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Phase 2/3 Study To Investigate The Safety And Efficacy Of Brepocitinib In Adults With Lichen Planopilaris (ALPINE) - Mayo Clinic

    The purpose of this study is to determine the safety and efficacy of brepocitinib (a tyrosine kinase [TYK]2/Janus kinase [JAK]1 inhibitor) in adult participants ...